divis
beat cent lower estim
dec adjust ep cent vs cent year earlier cent higher
ep vs record revenu
ep estim held back target
equip inventori reduct new manag invest effici cross sell
introduc ep estim project
lead world-wide dental product manufactur report dec adjust ep
cent vs cent last year compar report year-over-year period yoy unless otherwis indic
cent higher estim exclud adjust ep impair charg million
compris million relat indefinit life intang asset million goodwil result
target million equip inventori reduct due less-than-anticip retail sell-through
lower project growth rate cad/cam equip increas competit chang fx
project impact fair valu chang tax foreign exchang rate due impair list
new tax law recent manag chang compani unabl file
within allow time-frame file extens manag indic easili meet
sale million project exclud preciou metal pm content million vs
million normal impact commod gold/silv price show sale exclud pm
earn model separ line item sale yoy billion sale rose organ
basi acquisit ad bp fx ad bp
consum ex-pm sale intern broad growth across categori
equip rose led million inventori build million million
inventori reduct rest world row implant return growth two year
packag digit impress implant creat opportun cross sell product compani
see abil combin differenti product one offer potenti growth driver
vs last quarter driven million inventori build europ vs driven
stronger equip growth row rose lower-than-expect vs impact
pleas see import disclosur end report
sirona integr equip margin neg
gross margin vs sg expens decreas revenu vs adjust
oper profit million increas bp yoy ex-pm sale net interest
adjust expens million vs million adjust tax rate around vs
adjust net incom million increas yoy ex-pm net profit margin bp yoy
sale
revenu ex-pm billion intern growth flat fx ad
intern europ grew row decreas adjust oper profit
million oper margin fell bp yoy ex-pm sale core oper tax
rate around vs adjust net incom increas flat million per share vs
record after-tax return averag asset equiti pre-tax return invest capit
vs respect report basi net
loss billion vs incom million loss per share vs ep
balanc sheet decemb show cash equival million account receiv
rose yoy vs sale increas million dso vs inventori
yoy million day calcul month data vs total debt around
billion compar equiti billion debt-to-tot capit ratio vs year
earlier high septemb acquisit astratech compani target
net cash ratio
flow oper cfo million vs million year earlier million
vs million adjust net incom vs free cash flow priorit
order import reinvest busi accret compani note million small
tuck-in stock buyback dividend rais februari per quarter
believ share repurchas quarter
sale earn outlook
januari dentspli appoint donald casey jr ceo board member see januari
wire addit detail succeed interim ceo mark thierer februari three week
job mr casey highlight need renew focu custom compani believ
intern focus merger sale forc close peopl
global sale forc effect target improv emphasi product messag
train product tool custom servic includ teach salesforc effect cross sell
equip consum dentspli creat new program facilit cross
sell similar implant imag note mr casey reiter previou manag target
million cost save next two year one-half realiz area
procur ration manufactur footprint make oper model effici
previous mention dentspli enter three-year agreement distributor henri schein
went effect septemb distribut compani full line dental equip north america
addit product alreadi offer april dentspli imag equip abl integr
dentist practic manag softwar could help boost sale back half
year dentspli also recent negoti long-term agreement previous
equip exclus drive innov compani indic batch new product launch
pleas see import disclosur end report
divis wellington shield co llc
corpor
cad/cam area plan bolster disciplin salesforc take proactiv role
schein patterson suggest may reli heavili distributor past develop lead
take respons busi benefit expect begin back half year
distributor access full line dentspli product agreement ultim help dentspli
drive adopt single-visit dentistri cerec system around penetr
compani guidanc includ intern growth rate impact million target
inventori channel reduct earli tough comp europ ep
estim cent vs cent year earlier cent previous top-lin million ex-pm
ep estim vs record adjust compani guidanc
previous revenu billion vs billion compani guidanc
billion compani guidanc includ materi share repurchas recent growth
invest take month materi benefit start back half
 equip expect grow mid-singl digit long-term cad/cam
margin expect flat slightli versu effici improv off-set foreign
exchang effect headwind million target inventori reduct especi impact
first half year forecast oper net margin ex-pm revenu
respect vs respect tax rate model vs new
 tax law reduc valu dentspli foreign tax credit impact cent per share capit spend
estim around million exclud amort purchas intang around
million million dividend million result gross/fre cash flow
ep estim introduc project revenu
billion assum progress initi note forecast oper margin ex-pm
revenu net interest expens model million tax rate net margin
project bp ex-pm revenu net incom ep forecast
respect year share count model flat
share sell forward ep estim project
year ep growth rate rate hold due valuat share trade
trail price-to-report earn ratio current sell
estim ebitda million around estim ebitda billion short
posit million share februari equal days-to-cov base averag daili volum
day million share million trade per day
realiz expect revenue/cost synergi sirona major risk compound recent
manag chang middl integr compani report investig
sec divis enforc regard account disclosur worth note pwc
compani auditor sign financi statement without request extens scrutin
report impact econom condit includ job loss procedur deferr trade-down
result risk sale outsid compani expos fx
fluctuat well effect sale forc abl satisfactorili servic countri gener
reimburs concern impact result signific impact outsid
particularli germani limit reimburs domest anoth consider regulatori
pleas see import disclosur end report
divis wellington shield co llc
corpor
environ includ fda regul introduct manufactur advertis label packag
market distribut product
pleas see import disclosur end report
divis wellington shield co llc
-- earn model -- march
dec year-end
million except per share data
good sold
good sold
pleas see import disclosur end report
